119 related articles for article (PubMed ID: 8357945)
1. Impurities in organic synthetic drugs: a review of regulatory and toxicological considerations.
Mahoney K; Scales MD; Tucker ML
Adverse Drug React Toxicol Rev; 1993; 12(2):129-38. PubMed ID: 8357945
[No Abstract] [Full Text] [Related]
2. Sales of contaminated animal drugs halted.
Henkel J
FDA Consum; 1999; 33(5):34. PubMed ID: 10522171
[No Abstract] [Full Text] [Related]
3. A urinous tale.
Fitzpatrick M
Lancet; 2003 Mar; 361(9359):792. PubMed ID: 12620777
[No Abstract] [Full Text] [Related]
4. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
[No Abstract] [Full Text] [Related]
5. [Contamination in illegal amphetamine. Contaminants resulting from the synthesis of 3,4-(methylenedioxy)amphetamine (MDA) via condensation between nitroethane and piperonal].
Verweij AM; Sprong AG
Arch Kriminol; 1992; 190(1-2):24-8. PubMed ID: 1417396
[TBL] [Abstract][Full Text] [Related]
6. Victory for NICE as High Court rejects drugs firm complaints.
Evans O
Health Serv J; 2007 Aug; 117(6069):5. PubMed ID: 17847890
[No Abstract] [Full Text] [Related]
7. Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals.
Schweitzer SO
N Engl J Med; 2008 Apr; 358(17):1773-7. PubMed ID: 18434648
[No Abstract] [Full Text] [Related]
8. Playing "kick the FDA"--risk-free to players but hazardous to public health.
Wood AJ
N Engl J Med; 2008 Apr; 358(17):1774-5. PubMed ID: 18434649
[No Abstract] [Full Text] [Related]
9. Triazolam licensing in UK.
Brahams D
Lancet; 1993 Jun; 341(8860):1587. PubMed ID: 8099654
[No Abstract] [Full Text] [Related]
10. A bad trip: lawmakers try to stay one step ahead of the chemists manufacturing dangerous synthetic drugs.
Lawrence A
State Legis; 2011 Jun; 37(6):28-9. PubMed ID: 21667572
[No Abstract] [Full Text] [Related]
11. Hemophiliac class action suit.
George JE; Weisfeld NE
N J Med; 1994 Nov; 91(11):750. PubMed ID: 7808687
[No Abstract] [Full Text] [Related]
12. Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.
Basak AK; Raw AS; Al Hakim AH; Furness S; Samaan NI; Gill DS; Patel HB; Powers RF; Yu L
Adv Drug Deliv Rev; 2007 Jan; 59(1):64-72. PubMed ID: 17196703
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous profiling of organic and inorganic impurities in α-pyrrolidinopentiophenone (α-PVP).
Hattori N; Kaizaki-Mitsumoto A; Hataoka K; Numazawa S
J Toxicol Sci; 2019; 44(12):849-857. PubMed ID: 31813904
[TBL] [Abstract][Full Text] [Related]
14. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
[TBL] [Abstract][Full Text] [Related]
15. Administrative detention of drugs intended for human or animal use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 May; 79(103):30716-21. PubMed ID: 24873018
[TBL] [Abstract][Full Text] [Related]
16. The assessment of impurities for genotoxic potential and subsequent control in drug substance and drug product.
Dow LK; Hansen MM; Pack BW; Page TJ; Baertschi SW
J Pharm Sci; 2013 May; 102(5):1404-18. PubMed ID: 23436613
[TBL] [Abstract][Full Text] [Related]
17. Drug company bosses jailed for selling HIV infected products.
Lamar J
BMJ; 2000 Mar; 320(7235):601. PubMed ID: 10698870
[No Abstract] [Full Text] [Related]
18. Pharmaceutical impurities: analytical, toxicological and regulatory perspectives.
Basak AK; Raw AS; Yu LX
Adv Drug Deliv Rev; 2007 Jan; 59(1):1-2. PubMed ID: 17196297
[No Abstract] [Full Text] [Related]
19. Drug patent protection: how long is long enough?
Sibbald B
CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
[No Abstract] [Full Text] [Related]
20. Contaminated dietary supplements.
Carvajal R
N Engl J Med; 2010 Jan; 362(3):274; author reply 274. PubMed ID: 20089984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
